Cutaneous Squamous Cell Carcinoma Subjected to Anti PD-1 Immunotherapy: Monitoring Response Through Serial PET/CT Scans with <sup>18</sup>F-FDG-Reference-Cited by-同舟云学术

Cutaneous Squamous Cell Carcinoma Subjected to Anti PD-1 Immunotherapy: Monitoring Response Through Serial PET/CT Scans with ¹⁸F-FDG

Published:2022-04-01 Issue:3 Volume:37 Page:226-232
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Filippi Luca¹^ORCID,Proietti Ilaria²,Petrozza Vincenzo³,Bagni Oreste¹,Schillaci Orazio⁴⁵

Affiliation:

1. Department of Nuclear Medicine, Santa Maria Goretti Hospital, Latina, Italy.

2. Dermatology Unit “Daniele Innocenzi,” “A. Fiorini” Hospital, Terracina, Italy.

3. Department of Medico-Surgical Sciences and Biotechnologies, Pathology Unit, ICOT Hospital, “Sapienza” University of Rome, Latina, Italy.

4. Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy.

5. IRCCS Neuromed, Pozzilli, Italy.

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/cbr.2021.0368

Reference16 articles.

1. Advanced cutaneous squamous cell carcinoma: real world data of patient profiles and treatment patterns

2. Immunotherapy for Non-melanoma Skin Cancer

3. Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma

4. Molecular imaging in immuno-oncology: current status and translational perspectives

5. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Prognostic Role of [¹⁸F]FDG PET/CT in Patients with Advanced Cutaneous Squamous Cell Carcinoma Submitted to Cemiplimab Immunotherapy: A Single-Center Retrospective Study;Cancer Biotherapy and Radiopharmaceuticals;2023-10-26

2. Cemiplimab for the Treatment of Advanced Cutaneous Squamous Cell Carcinoma: Appropriate Patient Selection and Perspectives;Clinical, Cosmetic and Investigational Dermatology;2023-08

3. Cemiplimab;Reactions Weekly;2022-10-08

4. The Role and Potential of 18F-FDG PET/CT in Malignant Melanoma: Prognostication, Monitoring Response to Targeted and Immunotherapy, and Radiomics;Diagnostics;2022-04-08